51963-82-7 Usage
Uses
Used in Pharmaceutical Industry:
2,5-Diethoxy-4-(4-morpholinyl)benzenamine is used as a chemical intermediate for the synthesis of various drugs. Its unique structure allows for further chemical reactions that can lead to the development of new pharmaceutical compounds.
Used in Biochemical Research:
2,5-Diethoxy-4-(4-morpholinyl)benzenamine is used as a research compound in biochemical studies. Its complex structure and reactivity make it a valuable tool for understanding various biochemical processes and interactions.
Safety Considerations:
Due to its chemical nature, 2,5-Diethoxy-4-(4-morpholinyl)benzenamine must be handled with care and appropriate safety procedures to avoid risks. While specific data on toxicity, dangers, and environmental impact are not widely documented, it is essential to follow general safety measures as a standard protocol when working with 2,5-Diethoxy-4-(4-morpholinyl)benzenamine.
Check Digit Verification of cas no
The CAS Registry Mumber 51963-82-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,9,6 and 3 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 51963-82:
(7*5)+(6*1)+(5*9)+(4*6)+(3*3)+(2*8)+(1*2)=137
137 % 10 = 7
So 51963-82-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H22N2O3/c1-3-18-13-10-12(16-5-7-17-8-6-16)14(19-4-2)9-11(13)15/h9-10H,3-8,15H2,1-2H3
51963-82-7Relevant academic research and scientific papers
VEGFR TYROSINE KINASE INHIBITORS
-
Page/Page column 33, (2014/12/12)
Novel compounds, their prodrugs, and the pharmaceutically acceptable salts as pharmaceutical compositions containing such compounds useful in treating certain diseases modulated by the inhibition of vascular endothelial growth factors (VEGFs) receptor tyrosine kinases are provided. In particular, compounds and compositions and the methods for the prophylaxis, management and treatment of cancers through the inhibition of VEGF receptor tyrosine kinases are provided.
